EZH2 is a core enzymatic component of polycomb repressive complex 2 (Figure 1A), associated with rapid progression in various cancers such as prostate and breast cancer.4,5 Information regarding the association of the ACC histopathological patterns and clinical characteristics with the EZH2 protein expression is scarce. The gene discussed is EZH2; the disease is cancer.